MedPath

Effect of BMI and body fat percentage on pharmacokinetics and analgesic effect of fentanyl after trasndermal fentanyl patch administratio

Not Applicable
Recruiting
Conditions
cancer-related pain
Registration Number
JPRN-UMIN000009346
Lead Sponsor
Kanazawa University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) history of hypersensitivity to fentanyl patch 2) concomitant use of other opioids (except for rescue) 3) concomitant use of azole antifungi drugs or steroids pulse therapy 4) bone metastasis 5) palliative radiation therapy 6) sever liver disease (AST or ALT, 100 IU/L or higher) 7) sever kidney disease (BUN 25 mg/dl or higher, or serum creatinine 2.0 mg/dL or higher) 8) other situation that doctor decides

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath